Prevalence and impact of hepatitis B and C virus co-infections in antiretroviral treatment naïve patients with HIV infection at a major treatment center in Ghana.
about
Prevalence of HIV and hepatitis B coinfection in Ghana: a systematic review and meta-analysisPrevalence and Characteristics of Hepatitis B Virus (HBV) Coinfection among HIV-Positive Women in South Africa and BotswanaSero-prevalence of hepatitis B virus and hepatitis C virus among HIV patients in a suburban University Teaching Hospital in South-East NigeriaHepatitis B and Delta virus are prevalent but often subclinical co-infections among HIV infected patients in Guinea-Bissau, West Africa: a cross-sectional studyProportion and factors associated with Hepatitis B viremia in antiretroviral treatment naïve and experienced HIV co-infected Ghanaian patients.Sero-prevalence and associated risk factors for hepatitis C virus infection among voluntary counseling testing and anti retroviral treatment clinic attendants in Adwa hospital, northern Ethiopia.Hepatitis B in Ghana: a systematic review & meta-analysis of prevalence studies (1995-2015)Limited Genetic Diversity of Hepatitis B Virus in the General Population of the Offin River Valley in GhanaEpidemiology of hepatitis C virus in Ghana: a systematic review and meta-analysis.Rates and impact of hepatitis on human immunodeficiency virus infection in a large African cohortShort-term treatment outcomes in human immunodeficiency virus type-1 and hepatitis B virus co-infectionsAntibody screening tests variably overestimate the prevalence of hepatitis C virus infection among HIV-infected adults in Ghana.Assessment of hepatitis B virus and hepatitis C virus infections and associated risk factors in HIV infected patients at Debretabor hospital, South Gondar, Northwest Ethiopia.Human pegivirus (HPgV) infection in Ghanaians co-infected with human immunodeficiency virus (HIV) and hepatitis B virus (HBV).
P2860
Q26748768-F48A8691-CE93-4C5B-A372-BE05485520ADQ28546809-602D768B-521F-4D53-A666-9158425889C0Q28658980-8E542C94-2E5D-487C-B5BB-DAF45CCF6329Q33734612-8FE24E88-D985-4E4E-88A1-F9C96587975DQ35892317-2BC8A3DC-2A70-41ED-AA60-59E286D1FB63Q35932185-47AF12C7-AC36-4E53-A980-76C9A381B81CQ35961475-3A761E18-A9E1-44D4-9698-6F1A538D23F3Q36043480-9B16C674-B025-4A68-9F5C-F37FD395D93CQ36099733-81778599-6616-489C-A225-EA20F0911D1CQ36699205-7A4D5181-9A10-47EB-BDC4-9C562C743842Q36960592-33E7AC4B-227A-470A-B1F9-6F5DF4FF98EBQ41662784-C88D5B9A-E818-4B35-843F-619225D4999DQ45989708-57D6A799-636B-4944-BFC5-5B47A4051EAFQ52725955-796299FB-6DF3-4672-9720-590B8007EA86
P2860
Prevalence and impact of hepatitis B and C virus co-infections in antiretroviral treatment naïve patients with HIV infection at a major treatment center in Ghana.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Prevalence and impact of hepat ...... jor treatment center in Ghana.
@en
Prevalence and impact of hepat ...... jor treatment center in Ghana.
@nl
type
label
Prevalence and impact of hepat ...... jor treatment center in Ghana.
@en
Prevalence and impact of hepat ...... jor treatment center in Ghana.
@nl
prefLabel
Prevalence and impact of hepat ...... jor treatment center in Ghana.
@en
Prevalence and impact of hepat ...... jor treatment center in Ghana.
@nl
P2093
P2860
P356
P1476
Prevalence and impact of hepat ...... jor treatment center in Ghana.
@en
P2093
Afrakoma Adjoa Agyei
Francesca Ziga
Julius Abraham Addo Mingle
Kwamena William Coleman Sagoe
Makafui Seshi
Margaret Lartey
Max Q Arens
Theophilus K Adiku
P2860
P356
10.1002/JMV.22262
P577
2012-01-01T00:00:00Z